| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $270,336 | 7 | 100 |
Sells | $0 | 0 | 0 |
| Schall Thomas J. | director | 1 | $101,041 | 0 | $0 | $101,041 |
| Feinberg Peter | director | 1 | $86,904 | 0 | $0 | $86,904 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 2 | $35,547 | 0 | $0 | $35,547 |
| Brakewood Harold Eugene | Chief Business Officer | 1 | $24,990 | 0 | $0 | $24,990 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 1 | $10,948 | 0 | $0 | $10,948 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | 1 | $10,906 | 0 | $0 | $10,906 |
Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS and/or RAF gene mutations. The second is IMM-6-415, which is being developed to treat solid tumors. Beyond these advanced-stage …
Over the last 12 months, insiders at Immuneering Corporation have bought $270,336 and sold $0 worth of Immuneering Corporation stock.
On average, over the past 5 years, insiders at Immuneering Corporation have bought $352,949 and sold $3.91M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schall Thomas J. (director) — $101,041. Feinberg Peter (director) — $86,904. Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) — $35,547.
The last purchase of 2,400 shares for transaction amount of $10,948 was made by Zeskind Benjamin J. (PRESIDENT AND CEO) on 2026‑06‑23.
| 2026-06-23 | Zeskind Benjamin J. | PRESIDENT AND CEO | 2,400 0.0066% | $4.56 | $10,948 | -1.76% | ||
| 2026-06-15 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 6,035 0.0165% | $4.15 | $25,045 | +6.09% | ||
| 2026-01-16 | Brakewood Harold Eugene | Chief Business Officer | 5,250 0.015% | $4.76 | $24,990 | +8.30% | ||
| 2026-01-15 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 2,298 0.0062% | $4.57 | $10,502 | +6.90% | ||
| 2026-01-15 | Schall Thomas J. | director | 21,645 0.06% | $4.67 | $101,041 | +6.90% | ||
| 2026-01-13 | Neufeld Leah R | CHIEF PEOPLE OFFICER | 2,626 0.0073% | $4.15 | $10,906 | +19.57% | ||
| 2026-01-12 | Feinberg Peter | director | 20,000 0.0567% | $4.35 | $86,904 | +17.30% | ||
| 2025-10-03 | Feinberg Peter | director | 7,500 0.0197% | $6.67 | $50,025 | -14.30% | ||
| 2025-10-01 | Morales Mallory | Chief Accounting Officer | 300 0.0008% | $6.39 | $1,917 | -18.40% | ||
| 2025-10-01 | Neufeld Leah R | CHIEF PEOPLE OFFICER | 800 0.002% | $6.38 | $5,103 | -18.40% | ||
| 2025-10-01 | Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | 1,020 0.0027% | $6.83 | $6,967 | -18.40% | ||
| 2025-09-30 | Feinberg Peter | director | 7,500 0.0208% | $7.03 | $52,730 | -25.71% | ||
| 2025-09-29 | Feinberg Peter | director | 5,000 0.0147% | $7.18 | $35,900 | -22.96% | ||
| 2025-07-02 | Zeskind Benjamin J. | PRESIDENT AND CEO | 7,015 0.0192% | $3.53 | $24,792 | +46.80% | ||
| 2025-07-02 | Neufeld Leah R | CHIEF PEOPLE OFFICER | 700 0.0019% | $3.57 | $2,499 | +46.80% | ||
| 2025-07-02 | HAUSMAN DIANA | director | 5,500 0.0154% | $3.61 | $19,863 | +46.80% | ||
| 2025-07-01 | Zeskind Benjamin J. | PRESIDENT AND CEO | 2,985 0.0081% | $3.38 | $10,087 | +53.20% | ||
| 2025-06-27 | Schall Thomas J. | director | 9,500 0.0274% | $3.66 | $34,788 | +50.00% | ||
| 2025-06-23 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 6,007 0.0166% | $2.43 | $14,596 | +115.98% | ||
| 2025-06-20 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 7,415 0.0217% | $2.70 | $20,020 | +106.84% |
| Zeskind Benjamin J. | PRESIDENT AND CEO | 2315252 3.575% | $8.52M | 8 | 0 | +3.51% |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 382531 0.5907% | $1.41M | 8 | 0 | +32.29% |
| Feinberg Peter | director | 135441 0.2091% | $498,422.88 | 12 | 0 | <0.0001% |
| Schall Thomas J. | director | 74530 0.1151% | $274,270.40 | 4 | 0 | +69.13% |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | 25970 0.0401% | $95,569.60 | 4 | 0 | <0.0001% |
| Brakewood Harold Eugene | Chief Business Officer | 11050 0.0171% | $40,664.00 | 3 | 0 | +37.34% |
| Cormorant Asset Management, LP | 10 percent owner | 2895273 4.4706% | $10.65M | 1 | 3 | <0.0001% |
| CARPENTER ROBERT J | director | 1148839 1.7739% | $4.23M | 1 | 0 | <0.0001% |
| BERMAN ANN E | director | 67465 0.1042% | $248,271.20 | 3 | 0 | <0.0001% |
| Morales Mallory | Chief Accounting Officer | 27533 0.0425% | $101,321.44 | 3 | 0 | <0.0001% |
| KEATING LAURIE | 14000 0.0216% | $51,520.00 | 2 | 0 | <0.0001% | |
| Amin Biren | CFO, TREASURER | 7898 0.0122% | $29,064.64 | 2 | 0 | <0.0001% |
| Barrett Scott | CHIEF MEDICAL OFFICER | 7563 0.0117% | $27,831.84 | 2 | 0 | <0.0001% |
| Bookman Michael | CHIEF LEGAL OFFICER, SECRETARY | 4870 0.0075% | $17,921.60 | 3 | 0 | <0.0001% |
| HAUSMAN DIANA | director | 3000 0.0046% | $11,040.00 | 1 | 0 | +46.8% |
$22,710,871 | 107 | 8.53% | $220.62M | |
$6,146,922 | 96 | -4.70% | $233.68M | |
$60,836,085 | 69 | 0.45% | $255.44M | |
Immuneering Corporation (IMRX) | $19,239,249 | 50 | -2.24% | $238.33M |
$168,352,523 | 35 | 13.58% | $218.79M |
| Increased Positions | 58 | +82.86% | 10M | +39.24% |
| Decreased Positions | 27 | -38.57% | 5M | -18.15% |
| New Positions | 30 | New | 4M | New |
| Sold Out Positions | 15 | Sold Out | 4M | Sold Out |
| Total Postitions | 101 | +44.29% | 32M | +21.09% |
| Fmr Llc | $58,170.00 | 13.52% | 8.79M | +9M | +3,876.04% | 2025-09-30 |
| Sanofi | $17,931.00 | 4.17% | 2.71M | +3M | New | 2025-09-30 |
| Vanguard Group Inc | $15,989.00 | 3.72% | 2.42M | +1M | +128.52% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $11,908.00 | 2.77% | 1.8M | +2M | New | 2025-09-30 |
| Exoduspoint Capital Management, Lp | $10,041.00 | 2.33% | 1.52M | +2M | New | 2025-09-30 |
| Logos Global Management Lp | $6,289.00 | 1.46% | 950,000 | +950,000 | New | 2025-09-30 |
| Citadel Advisors Llc | $6,244.00 | 1.45% | 943,144 | +943,144 | New | 2025-09-30 |
| Blackrock, Inc. | $4,509.00 | 1.05% | 681,185 | +258,427 | +61.13% | 2025-09-30 |
| Blue Owl Capital Holdings Lp | $3,641.00 | 0.85% | 550,000 | +550,000 | New | 2025-09-30 |
| Geode Capital Management, Llc | $3,400.00 | 0.79% | 513,665 | +283,390 | +123.07% | 2025-09-30 |